Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · IEX Real-Time Price · USD
7.85
+0.06 (0.77%)
At close: Jul 19, 2024, 4:00 PM
8.13
+0.28 (3.57%)
Pre-market: Jul 22, 2024, 6:34 AM EDT
Vicarious Surgical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Vicarious Surgical stock have an average target of 17.33, with a low estimate of 10 and a high estimate of 30. The average target predicts an increase of 120.76% from the current stock price of 7.85.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for RBOT stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | +27.39% | Jul 15, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $45 → $30 | Hold | Maintains | $45 → $30 | +282.17% | Mar 5, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $18 | Hold | Initiates | $18 | +129.30% | Dec 4, 2023 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 14, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $270 → $12 | Strong Buy → Hold | Downgrades | $270 → $12 | +52.87% | Nov 14, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-11.32
from -14.70
EPS Next Year
-12.55
from -11.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 37.8M | 58.0M |
| Avg | n/a | n/a | n/a | 31.2M | 56.3M |
| Low | n/a | n/a | n/a | 20.5M | 54.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 85.5% |
| Avg | - | - | - | - | 80.2% |
| Low | - | - | - | - | 73.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -10.71 | -11.66 | -10.08 | -8.19 |
| Avg | -11.32 | -12.55 | -12.16 | -10.56 |
| Low | -12.05 | -14.41 | -13.52 | -12.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.